Biden administration appeals Texas court decision striking down free Obamacare coverage of preventive care

Biden administration appeals Texas court decision striking down free Obamacare coverage of preventive care


The Biden administration on Friday appealed a Texas federal judge’s decision to strike down free Obamacare coverage of preventive health-care services ranging from screenings for certain cancers and diabetes to HIV prevention drugs.

U.S. Judge Reed O’Connor of the U.S. Northern District Court of Texas on Thursday struck down an Obamacare mandate requiring most private insurance plans to cover certain types of health care recommended an independent panel of experts called the Preventive Services Task Force.

“Preventive care is an essential part of health care: it saves lives, saves families money, and improves our nation’s health,” said Kamara Jones, a Health and Human Services spokesperson, on Thursday evening after the judge’s ruling. “Actions that strip away this decade-old protection are backwards and wrong.” 

The case will now go to U.S. Fifth Circuit Court of Appeals. A majority of the judges on that court were appointed by Republican presidents.

HHS estimates that 150 million Americans benefited from the free screenings, counseling, medications and other forms of health care that prevent disease under the Obamacare requirements.

Lawrence Gostin, an expert on health law at Georgetown University, said most private insurance plans will probably continue to cover these services but charge copays and deductibles. Working class Americans will get hit the hardest and might forgo essential health care because they can’t afford the cost, Gostin said.

O’Connor ruled that Obamacare cannot mandate free coverage of health care recommended by the Preventive Services Task Force because the organization’s members were appointed in an illegal manner.

Here is a list of the preventive health services that the judge’s ruling likely applies to

Two business owners and several individuals sued the U.S. in March 2020 over the preventive health services mandate, arguing that buying insurance that covers drugs that prevent HIV infection violates their Christian religious beliefs.

The plaintiffs claimed in their suit that the mandate to cover HIV prevention drugs “forces religious employers to provide coverage for drugs that facilitate and encourage homosexual behavior, prostitution, sexual promiscuity, and intravenous drug use.”

They also argued the Preventive Services Task Force was appointed in an unconstitutional manner and therefore its recommendations cannot serve as the basis of an Obamacare mandate.

This is a developing story. Please check back for updates.

Join CNBC’s Healthy Returns on March 29th, where we’ll convene a virtual gathering of CEOs, scientists, investors and innovators in the health care space to reflect on the progress made today to reinvent the future of medicine. Plus, we’ll have an exclusive rundown of the best investment opportunities in biopharma, health-tech and managed care. Learn more and register today: 



Source

Healthy Returns: What to expect from pharma at the JPM conference
Health

Healthy Returns: What to expect from pharma at the JPM conference

Heidi Overton, Novo Nordisk CEO Maziar Mike Doustdar, Eli Lilly CEO David A. Ricks, and U.S. Secretary of Commerce Howard Lutnick listen while U.S. President Donald Trump announces a deal with Eli Lilly and Novo Nordisk on to reduce the prices of GLP-1 weight‑loss drugs during an event in the Oval Office at the White […]

Read More
A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
Health

A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year

Europe’s best-performing blue-chip stock in 2025 is widely expected to be bought by a larger peer, in a deal analysts say could be worth as much as $23 billion. Abivax, the French clinical-stage biotech company developing a treatment for ulcerative colitis and Crohn’s disease, saw shares rocket 1,681% last year, far outpacing the Stoxx 600 […]

Read More
Patient advocacy groups urge U.S. court to halt overseas prescription drug operations
Health

Patient advocacy groups urge U.S. court to halt overseas prescription drug operations

In a photo illustration, prescription drugs are seen next to a pill bottle on July 23, 2024 in New York. Spencer Platt | Getty Images News | Getty Images A coalition of patient advocacy groups is urging a federal court to halt the practices of third-party companies that buy drugs from countries outside the FDA-regulated […]

Read More